Search
Close this search box.

[:pb]Synthesis and First-Time Assessment of o-Eugenol Derivatives against Mycobacterium tuberculosis[:]

[:pb]Authors: Moraes, A. M.; Da Silva, E. T. ; Wardell, J. L. ; De Souza, M. V. N.
Source: Chemistry of Natural Compounds, v. 56, p. 633-638, 2020
Publisher: Springer


Abstract

In this work, we report the first-time assessment of o-eugenol, 6-allyl-2-methoxyphenol, and their selected derivatives, against Mycobacterium tuberculosis H37RV, using the MABA susceptibility test. The bromo, nitro, O-alkylated, and reduced derivatives were obtained by standard methods and were characterized by spectroscopic and mass spectral data. Structure–activity relationships were investigated, with the most active derivatives being 4,5-dibromo-2-methoxy-6-propylphenol (139 μM) and 2-methoxy-3-nitro-6-propylphenol (237 μM). This study provides important information on the rational design of new lead anti-TB drugs based on o-eugenol derivatives.


Keywords: eugenol, o-eugenol, synthesis, tuberculosis, Mycobacterium tuberculosis, nitration, bromination, large scale

Document Type: Research Article

DOI: 10.1007/s10600-020-03110-2

Publication date: 24 de julho de 2020[:]

Compartilhar publicação

Facebook
Twitter
Email
LinkedIn
WhatsApp

Deixe seu comentário

Compartilhar

Sobre a SSCDT

Nosso grupo de pesquisa está situado em Farmanguinhos e atualmente é o maior laboratório farmacêutico oficial vinculado ao Ministério da Saúde. Farmanguinhos produz mais de um bilhão de medicamentos por ano para os programas estratégicos do Governo Federal, além de atender demandas emergenciais no Brasil e no exterior.

posts Recentes